LTC2422766I2 - Glikopirolato ir magnio stearato sausų miltelių kompozicijos - Google Patents

Glikopirolato ir magnio stearato sausų miltelių kompozicijos

Info

Publication number: LTC2422766I2
Authority: LT; Lithuania
Prior art keywords: glycopyrrolate; magnesium stearate; dry powder; powder formulations; stearate dry
Prior art date: 2004-04-30

Application number

LTPA2015053C

Other languages

English (en)

Original Assignee

Vectura Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-30

Filing date

2015-12-18

Publication date

2020-02-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32408337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC2422766(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-12-18 Application filed by Vectura Limited filed Critical Vectura Limited

2020-02-10 Publication of LTC2422766I2 publication Critical patent/LTC2422766I2/lt

Links

HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 title 2
VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 title 1
238000009472 formulation Methods 0.000 title 1
229940015042 glycopyrrolate Drugs 0.000 title 1
235000019359 magnesium stearate Nutrition 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000000843 powder Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LTPA2015053C 2004-04-30 2015-12-18 Glikopirolato ir magnio stearato sausų miltelių kompozicijos LTC2422766I2 (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0409703.6A GB0409703D0 (en)	2004-04-30	2004-04-30	Pharmaceutical compositions
EP05738040A EP1755555B1 (en)	2004-04-30	2005-04-29	Methods for preparing dry powder compositions of glycopyrrolate

Publications (1)

Publication Number	Publication Date
LTC2422766I2 true LTC2422766I2 (lt)	2020-02-10

Family

ID=32408337

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTPA2015053C LTC2422766I2 (lt)	2004-04-30	2015-12-18	Glikopirolato ir magnio stearato sausų miltelių kompozicijos

Country Status (26)

Country	Link
US (1)	US20080063719A1 (lt)
EP (3)	EP2422766B1 (lt)
JP (2)	JP5000483B2 (lt)
KR (1)	KR101287919B1 (lt)
CN (3)	CN102008453A (lt)
AU (2)	AU2005237266B2 (lt)
BR (1)	BRPI0510500B8 (lt)
CA (1)	CA2563760C (lt)
CY (6)	CY1113069T1 (lt)
DK (2)	DK1755555T3 (lt)
ES (2)	ES2388289T3 (lt)
GB (1)	GB0409703D0 (lt)
HU (4)	HUE025463T2 (lt)
IL (2)	IL178651A (lt)
LT (1)	LTC2422766I2 (lt)
LU (2)	LU92176I2 (lt)
MX (2)	MXPA06012493A (lt)
NO (1)	NO20065502L (lt)
NZ (1)	NZ550479A (lt)
PL (2)	PL1755555T3 (lt)
PT (2)	PT2422766E (lt)
RU (1)	RU2396943C2 (lt)
SG (3)	SG152292A1 (lt)
SI (2)	SI2422766T1 (lt)
WO (1)	WO2005105043A2 (lt)
ZA (1)	ZA200609350B (lt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
GB0425758D0 (en) *	2004-11-23	2004-12-22	Vectura Ltd	Preparation of pharmaceutical compositions
GB0525254D0 (en) *	2005-12-12	2006-01-18	Jagotec Ag	Powder compositions for inhalation
GB0613161D0 (en) *	2006-06-30	2006-08-09	Novartis Ag	Organic Compounds
GB0622818D0 (en) *	2006-11-15	2006-12-27	Jagotec Ag	Improvements in or relating to organic compounds
ES2460576T3 (es) *	2007-12-13	2014-05-13	Novartis Ag	Procedimiento para preparar una sustancia farmacológica en partículas y cristalina
JP2011506399A (ja) *	2007-12-13	2011-03-03	ノバルティスアーゲー	有機化合物
US20100055045A1 (en)	2008-02-26	2010-03-04	William Gerhart	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
GB2468073B (en) *	2008-02-26	2012-09-05	Elevation Pharmaceuticals Inc	Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
PL3578169T3 (pl)	2009-02-26	2024-09-02	Glaxo Group Limited	Preparaty farmaceutyczne zawierające 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
CN102458372A (zh) *	2009-04-24	2012-05-16	先灵公司	适用在干粉吸入器中的聚结物制剂
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
GB0921481D0 (en) *	2009-12-08	2010-01-20	Vectura Ltd	Process and product
WO2011121425A1 (en) *	2010-03-31	2011-10-06	Glenmark Pharmaceuticals Limited	Pharmaceutical powder composition for inhalation
BR112012024059B1 (pt)	2010-04-01	2021-06-01	Chiesi Farmaceutici S.P.A.	Processo de preparo de um excipiente para composições farmacêuticas em pó para inalação, partículas carreadoras para uma formulação farmacêutica de pó seco, composição farmacêutica em forma de pó seco para inalação e inalador de pó seco
DK2560611T3 (en) *	2010-04-21	2018-02-26	Chiesi Farm Spa	Process for providing particles with reduced electrostatic charges
AU2011298409B2 (en)	2010-08-31	2013-11-21	Glaxo Group Limited	Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
AU2011298315B2 (en)	2010-08-31	2014-08-28	Glaxo Group Limited	Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
JO3510B1 (ar)	2011-03-04	2020-07-05	Heptares Therapeutics Ltd	استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
BR112014025518B1 (pt)	2012-04-13	2022-05-24	Glaxosmithkline Intellectual Property Development Limited	Partículas agregadas de umeclidinium, vilanterol e fluticasona, composição em pó, inalador, processo para a preparação de partículas agregadas, e, uso de estearato de magnésio em partículas agregadas
AU2013100007B4 (en) *	2013-01-04	2013-05-23	Novartis Ag	System for treating chronic obstructive pulmonary disease
US8558008B2 (en)	2013-02-28	2013-10-15	Dermira, Inc.	Crystalline glycopyrrolate tosylate
KR20150119468A (ko)	2013-02-28	2015-10-23	더미라, 인코포레이티드	글리코피롤레이트 염
US9006462B2 (en)	2013-02-28	2015-04-14	Dermira, Inc.	Glycopyrrolate salts
HK1219059A1 (zh)	2013-03-15	2017-03-24	珍珠治疗公司	用於微粒晶体材料的状态调节的方法和系统
GB201305825D0 (en) *	2013-03-28	2013-05-15	Vectura Ltd	New use
US9393202B2 (en) *	2013-04-26	2016-07-19	Chiesi Farmaceutici S.P.A	Particle size reduction of an antimuscarinic compound
GB201402556D0 (en)	2014-02-13	2014-04-02	Crystec Ltd	Improvements relating to inhalable particles
SG11201700536XA (en) *	2014-09-09	2017-02-27	Vectura Ltd	Formulation comprising glycopyrrolate, method and apparatus
AU2015331915A1 (en) *	2014-10-16	2017-05-25	Teva Branded Pharmaceutical Products R&D, Inc.	Dry powder formulation
US9925168B2 (en)	2016-01-22	2018-03-27	Chiesi Farmaceutici S.P.A.	Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
AU2016397046B2 (en)	2016-03-08	2022-05-12	Mereo Biopharma 1 Limited	Dosage regimen for the treatment of acute exacerbations of inflammatory conditions
MX385717B (es)	2016-03-08	2025-03-18	Mereo Biopharma 1 Ltd	Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica.
PL3490533T3 (pl)	2016-07-29	2020-11-02	Inke, S.A.	Sposób stabilizacji rozmiaru cząstek
US10888546B2 (en)	2016-09-19	2021-01-12	Mexichem Fluor S.A. De C.V.	Pharmaceutical composition
WO2018167180A1 (en) *	2017-03-15	2018-09-20	Vectura Limited	Method and formulation
WO2019060595A1 (en)	2017-09-20	2019-03-28	Teva Branded Pharmaceutical Products R&D, Inc.	INHALABLE DRY POWDER MEDICINAL PRODUCT COMPRISING GLYCOPYRRONIUM
WO2019060604A1 (en) *	2017-09-20	2019-03-28	Teva Branded Pharmaceutical Products R&D, Inc.	INHALABLE MEDICINE
HUE055425T2 (hu)	2017-12-11	2021-11-29	Mereo Biopharma 1 Ltd	3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus elzáródásos tüdõbetegség akut fokozódásának kezelésében
PT3585383T (pt)	2017-12-11	2021-04-21	Mereo Biopharma 1 Ltd	Utilização de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-n-ciclopropil-4-metilbenzamida na prevenção ou redução de exacerbações graves da doença pulmonar obstrutiva crónica
KR102696616B1 (ko)	2018-12-21	2024-08-20	한미약품 주식회사	흡입 제형용 건조 분말 및 이의 제조방법
US20250050042A1 (en)	2021-12-21	2025-02-13	Chiesi Farmaceutici S.P.A.	Dry powder formulations filled in an inhaler with improved resistance to humidity
CN118475343A (zh)	2021-12-21	2024-08-09	凯西制药公司	填充在具有改善的耐湿性的吸入器中的干粉制剂

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2956062A (en) *	1959-02-26	1960-10-11	Robins Co Inc A H	Esters of amino alcohols
US3709039A (en) *	1970-08-31	1973-01-09	Gen Time Corp	Comfort humidity indicator
SE9302777D0 (sv) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
GB9501841D0 (en)	1995-01-31	1995-03-22	Co Ordinated Drug Dev	Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) *	1995-04-07	1997-03-18	Edward Mendell Co., Inc.	Controlled release insufflation carrier for medicaments
GB9808470D0 (en)	1998-04-22	1998-06-17	Smithkline Beecham Plc	Novel process and apparatus
CA2347856C (en) *	1998-11-13	2009-02-17	Jagotec Ag	Dry powder for inhalation
GB9826284D0 (en) *	1998-12-01	1999-01-20	Rhone Poulence Rorer Limited	Process
GB9826286D0 (en)	1998-12-01	1999-01-20	Rhone Poulence Rorer Limited	Process
GB0008660D0 (en) *	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
PE20011227A1 (es)	2000-04-17	2002-01-07	Chiesi Farma Spa	Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
IL153705A0 (en)	2000-06-27	2003-07-06	Vectura Ltd	Method of making particles for use in a pharmaceutical composition
JP4380988B2 (ja) *	2000-11-30	2009-12-09	ヴェクトゥラリミテッド	医薬組成物に用いられる粒子の製造方法
ES2587135T3 (es) *	2000-11-30	2016-10-20	Vectura Limited	Procedimiento de fabricación de partículas para su uso en una composición farmacéutica
PT1372608E (pt) *	2001-03-30	2008-01-04	Jagotec Ag	Formulações de aerossol médicas
JP2005530765A (ja) *	2002-05-07	2005-10-13	ネクターセラピューティクス	乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法
GB2405798A (en) *	2003-09-15	2005-03-16	Vectura Ltd	Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.
GB0409703D0 (en) *	2004-04-30	2004-06-02	Vectura Ltd	Pharmaceutical compositions
EP1861361A1 (en) *	2005-03-24	2007-12-05	Sosei R&D Ltd.	Glycopyrronium salts and their therapeutic use

2004
- 2004-04-30 GB GBGB0409703.6A patent/GB0409703D0/en not_active Ceased
2005
- 2005-04-29 SI SI200531999T patent/SI2422766T1/sl unknown
- 2005-04-29 PT PT111906376T patent/PT2422766E/pt unknown
- 2005-04-29 JP JP2007510045A patent/JP5000483B2/ja not_active Expired - Lifetime
- 2005-04-29 EP EP11190637.6A patent/EP2422766B1/en not_active Revoked
- 2005-04-29 SG SG200903001-6A patent/SG152292A1/en unknown
- 2005-04-29 KR KR1020067024763A patent/KR101287919B1/ko not_active Expired - Lifetime
- 2005-04-29 ES ES05738040T patent/ES2388289T3/es not_active Expired - Lifetime
- 2005-04-29 MX MXPA06012493A patent/MXPA06012493A/es active IP Right Grant
- 2005-04-29 PL PL05738040T patent/PL1755555T3/pl unknown
- 2005-04-29 CA CA2563760A patent/CA2563760C/en not_active Expired - Lifetime
- 2005-04-29 DK DK05738040.4T patent/DK1755555T3/da active
- 2005-04-29 WO PCT/EP2005/051980 patent/WO2005105043A2/en not_active Ceased
- 2005-04-29 EP EP11190638A patent/EP2422767A3/en not_active Withdrawn
- 2005-04-29 BR BRPI0510500A patent/BRPI0510500B8/pt not_active IP Right Cessation
- 2005-04-29 SI SI200531570T patent/SI1755555T1/sl unknown
- 2005-04-29 NZ NZ550479A patent/NZ550479A/en not_active IP Right Cessation
- 2005-04-29 HU HUE11190637A patent/HUE025463T2/en unknown
- 2005-04-29 CN CN2010105642463A patent/CN102008453A/zh active Pending
- 2005-04-29 RU RU2006142322/15A patent/RU2396943C2/ru active Protection Beyond IP Right Term
- 2005-04-29 DK DK11190637.6T patent/DK2422766T3/da active
- 2005-04-29 US US11/587,725 patent/US20080063719A1/en not_active Abandoned
- 2005-04-29 AU AU2005237266A patent/AU2005237266B2/en active Active
- 2005-04-29 SG SG2012093886A patent/SG186673A1/en unknown
- 2005-04-29 CN CN201710357916.6A patent/CN107252423A/zh active Pending
- 2005-04-29 PT PT05738040T patent/PT1755555E/pt unknown
- 2005-04-29 SG SG10201605001SA patent/SG10201605001SA/en unknown
- 2005-04-29 CN CNA200580013592XA patent/CN1964700A/zh active Pending
- 2005-04-29 EP EP05738040A patent/EP1755555B1/en not_active Revoked
- 2005-04-29 PL PL11190637T patent/PL2422766T3/pl unknown
- 2005-04-29 ES ES11190637.6T patent/ES2546982T3/es not_active Expired - Lifetime
2006
- 2006-10-16 IL IL178651A patent/IL178651A/en active IP Right Review Request
- 2006-10-27 MX MX2012008068A patent/MX341426B/es unknown
- 2006-11-10 ZA ZA2006/09350A patent/ZA200609350B/en unknown
- 2006-11-29 NO NO20065502A patent/NO20065502L/no not_active Application Discontinuation
2011
- 2011-02-09 AU AU2011200543A patent/AU2011200543B2/en not_active Expired
- 2011-11-08 JP JP2011244443A patent/JP5124718B2/ja not_active Expired - Lifetime
2012
- 2012-08-13 CY CY20121100722T patent/CY1113069T1/el unknown
- 2012-12-10 IL IL223545A patent/IL223545A/en active IP Right Grant
2013
- 2013-03-13 HU HUS1300006C patent/HUS1300006I1/hu unknown
- 2013-03-27 LU LU92176C patent/LU92176I2/fr unknown
- 2013-03-29 CY CY2013012C patent/CY2013012I2/el unknown
2014
- 2014-03-07 LU LU92392C patent/LU92392I2/xx unknown
- 2014-03-19 CY CY2014015C patent/CY2014015I1/el unknown
2015
- 2015-08-27 CY CY20151100754T patent/CY1116655T1/el unknown
- 2015-12-18 LT LTPA2015053C patent/LTC2422766I2/lt unknown
- 2015-12-21 HU HUS1500072C patent/HUS1500072I1/hu unknown
- 2015-12-21 HU HUS1500073C patent/HUS1500073I1/hu unknown
- 2015-12-23 CY CY2015059C patent/CY2015059I1/el unknown
- 2015-12-23 CY CY2015060C patent/CY2015060I1/el unknown

Also Published As

Publication number	Publication date
US20080063719A1 (en)	2008-03-13
IL178651A0 (en)	2007-02-11
IL178651A (en)	2012-12-31
CY2013012I1 (el)	2015-08-05
HUS1500073I1 (hu)	2016-02-29
AU2011200543B2 (en)	2012-11-29
CN102008453A (zh)	2011-04-13
CN1964700A (zh)	2007-05-16
EP2422767A3 (en)	2012-04-25
HK1095282A1 (en)	2007-05-04
SI1755555T1 (sl)	2012-10-30
JP5000483B2 (ja)	2012-08-15
EP2422766A3 (en)	2012-04-25
ZA200609350B (en)	2008-04-30
CY1113069T1 (el)	2015-08-05
CY2015060I1 (el)	2020-05-29
CY1116655T1 (el)	2017-03-15
HUS1500072I1 (hu)	2016-02-29
PT1755555E (pt)	2012-08-17
CY2014015I2 (el)	2015-12-09
MXPA06012493A (es)	2007-01-29
SG10201605001SA (en)	2016-08-30
RU2396943C2 (ru)	2010-08-20
EP2422766B1 (en)	2015-06-24
NZ550479A (en)	2009-11-27
LU92392I2 (fr)	2015-11-02
ES2388289T3 (es)	2012-10-11
LU92176I9 (lt)	2019-01-04
PT2422766E (pt)	2015-10-12
ES2546982T3 (es)	2015-09-30
EP2422767A2 (en)	2012-02-29
SI2422766T1 (sl)	2015-10-30
WO2005105043A3 (en)	2006-05-04
KR101287919B1 (ko)	2013-07-18
DK2422766T3 (da)	2015-08-31
AU2011200543A8 (en)	2011-03-31
CY2013012I2 (el)	2015-08-05
HUE025463T2 (en)	2016-02-29
AU2005237266A1 (en)	2005-11-10
MX341426B (es)	2016-08-18
BRPI0510500B1 (pt)	2019-04-24
JP2012031209A (ja)	2012-02-16
IL223545A0 (en)	2013-02-03
WO2005105043A2 (en)	2005-11-10
SG152292A1 (en)	2009-05-29
EP1755555A2 (en)	2007-02-28
CN107252423A (zh)	2017-10-17
KR20070033978A (ko)	2007-03-27
CY2014015I1 (el)	2015-12-09
JP2007535522A (ja)	2007-12-06
AU2011200543A1 (en)	2011-03-03
SG186673A1 (en)	2013-01-30
RU2006142322A (ru)	2008-06-20
BRPI0510500A (pt)	2007-10-30
HUS1300006I1 (hu)	2016-07-28
LU92176I2 (fr)	2013-05-27
EP2422766A2 (en)	2012-02-29
CA2563760A1 (en)	2005-11-10
EP1755555B1 (en)	2012-05-23
CA2563760C (en)	2013-07-02
CY2015059I1 (el)	2020-05-29
AU2005237266B2 (en)	2010-11-11
GB0409703D0 (en)	2004-06-02
IL223545A (en)	2016-04-21
DK1755555T3 (da)	2012-08-20
NO20065502L (no)	2007-01-24
PL2422766T3 (pl)	2015-11-30
JP5124718B2 (ja)	2013-01-23
PL1755555T3 (pl)	2012-11-30
HK1167334A1 (en)	2012-11-30
BRPI0510500B8 (pt)	2021-05-25

Publication	Publication Date	Title
LTC2422766I2 (lt)	2020-02-10	Glikopirolato ir magnio stearato sausų miltelių kompozicijos
LTC1901749I2 (lt)	2019-01-10	Aerozoliniai fluorchinolinai ir jų naudojimas
EP1848659A4 (en)	2009-08-12	DESOXYGENANT COMPOSITIONS AND PACKAGES COMPRISING SAID COMPOSITIONS
IL191287A0 (en)	2008-12-29	Atorvastatin formulation
IL183762A0 (en)	2008-04-13	Direct compression formulation and process
IL188602A0 (en)	2008-06-05	Non-flammable insecticide composition and uses thereof
IL185199A0 (en)	2008-01-06	Indole compound and use thereof
LT2101574T (lt)	2016-10-25	Junginiai ir kompozicijos, tinkami radikalo sujungimui
IL185223A0 (en)	2008-06-05	Compounds and uses thereof
EP1722639A4 (en)	2008-01-23	PROTECTED DRY COMPOSITES
GB0520743D0 (en)	2005-11-23	Compounds and their use
EP1967533A4 (en)	2011-01-12	PHOTORADICALALLY AND THERMALLY RADIALLICALLY CURABLE COMPOSITION
EP1911744A4 (en)	2010-06-02	TRYPTOPHANDERIVATE AND ITS USE
GB0515974D0 (en)	2005-09-07	Compounds and imaging methods
EP1810976A4 (en)	2007-10-17	BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF
NO20055559L (no)	2007-05-25	Plugg og fremgangsmate ved bruk av samme
IL191786A0 (en)	2008-12-29	Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
AU306389S (en)	2006-04-10	Handle and flange
AU306911S (en)	2006-05-22	Handle and flange
AU306915S (en)	2006-05-22	Handle and flange
AU306778S (en)	2006-05-15	Handle and flange
AU306780S (en)	2006-05-15	Handle and flange
AU306782S (en)	2006-05-15	Handle and flange
AU306913S (en)	2006-05-22	Handle and flange
AU307086S (en)	2006-05-29	Handle and flange